Arrivent Biopharma, Common Stock Price on October 29, 2024
| AVBP Stock | 29.11 0.37 1.29% |
If you're considering investing in ArriVent Stock, it is important to understand the factors that can impact its price. As of today, the current price of ArriVent BioPharma, stands at 29.11, as last reported on the 28th of November, with the highest price reaching 29.53 and the lowest price hitting 28.29 during the day. ArriVent BioPharma, appears to be not too volatile, given 3 months investment horizon. ArriVent BioPharma, secures Sharpe Ratio (or Efficiency) of 0.0545, which signifies that the company had a 0.0545% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for ArriVent BioPharma, Common, which you can use to evaluate the volatility of the firm. Please makes use of ArriVent BioPharma,'s Downside Deviation of 4.08, risk adjusted performance of 0.0374, and Mean Deviation of 2.72 to double-check if our risk estimates are consistent with your expectations.
As of 11/28/2024, Stock Based Compensation is likely to grow to about 1.1 M, while Total Stockholder Equity is likely to drop slightly above 134.6 M. . As of 11/28/2024, Price Earnings Ratio is likely to drop to -9.68. In addition to that, Price Book Value Ratio is likely to drop to 4.01. ArriVent Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
ArriVent |
Sharpe Ratio = 0.0545
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | AVBP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.71 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.2 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 4 96% of assets perform better |
Based on monthly moving average ArriVent BioPharma, is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ArriVent BioPharma, by adding it to a well-diversified portfolio.
Price Book 3.0805 | Book Value (55.80) | Enterprise Value 830.9 M | Shares Float 16.1 M | Shares Outstanding 33.7 M |
ArriVent BioPharma, Valuation on October 29, 2024
It is possible to determine the worth of ArriVent BioPharma, on a given historical date. On October 29, 2024 ArriVent was worth 31.96 at the beginning of the trading date compared to the closed value of 31.22. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of ArriVent BioPharma, stock. Still, in general, we apply an absolute valuation method to find ArriVent BioPharma,'s value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of ArriVent BioPharma, where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against ArriVent BioPharma,'s related companies.
| Open | High | Low | Close | Volume | |
| 32.07 | 32.40 | 31.61 | 32.17 | 122,981 | |
10/29/2024 | 31.96 | 32.19 | 30.70 | 31.22 | 74,372 |
| 31.02 | 32.00 | 31.02 | 31.47 | 59,953 |
| Backtest ArriVent BioPharma, | | | ArriVent BioPharma, History | | | ArriVent BioPharma, Valuation | Previous | Next |
ArriVent BioPharma, Trading Date Momentum on October 29, 2024
| On October 30 2024 ArriVent BioPharma, Common was traded for 31.47 at the closing time. The top price for the day was 32.00 and the lowest listed price was 31.02 . The trading volume for the day was 60 K. The trading history from October 30, 2024 was a factor to the next trading day price gain. The overall trading delta against the next closing price was 0.80% . The overall trading delta against the current closing price is 14.89% . |
ArriVent BioPharma, Fundamentals Correlations and Trends
By evaluating ArriVent BioPharma,'s financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among ArriVent BioPharma,'s main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. ArriVent financial account trend analysis is a perfect complement when working with valuation or volatility modules.About ArriVent BioPharma, Stock history
ArriVent BioPharma, investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for ArriVent is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in ArriVent BioPharma, will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing ArriVent BioPharma, stock prices may prove useful in developing a viable investing in ArriVent BioPharma,
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 28.8 M | 26.4 M |
ArriVent BioPharma, Quarterly Net Working Capital |
|
ArriVent BioPharma, Stock Technical Analysis
ArriVent BioPharma, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
ArriVent BioPharma, Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
ArriVent BioPharma, Common cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
ArriVent BioPharma, November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how ArriVent BioPharma, stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading ArriVent BioPharma, shares will generate the highest return on investment. By undertsting and applying ArriVent BioPharma, stock market strength indicators, traders can identify ArriVent BioPharma, Common entry and exit signals to maximize returns
ArriVent BioPharma, Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for ArriVent BioPharma,'s price direction in advance. Along with the technical and fundamental analysis of ArriVent Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of ArriVent to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0374 | |||
| Jensen Alpha | (0.02) | |||
| Total Risk Alpha | (0.42) | |||
| Sortino Ratio | 0.0039 | |||
| Treynor Ratio | 0.0995 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for ArriVent Stock Analysis
When running ArriVent BioPharma,'s price analysis, check to measure ArriVent BioPharma,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ArriVent BioPharma, is operating at the current time. Most of ArriVent BioPharma,'s value examination focuses on studying past and present price action to predict the probability of ArriVent BioPharma,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ArriVent BioPharma,'s price. Additionally, you may evaluate how the addition of ArriVent BioPharma, to your portfolios can decrease your overall portfolio volatility.